Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Phase 3 Study of Niraparib in Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

Disease Types: Prostate

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

For more information:

https://clinicaltrials.gov/ct2/show/NCT04497844?term=67652000PCR3002&draw=2&rank=1